Science Sparks @ ACTREC
Publications
- 1. Misra A, Phadte A, Subramani V, Dhanawat A, Menon S, Arora A, Nagarajan R, Maitre P, Pal M, Joshi A, Lila A, Prakash G, Murthy V (2026). Contemporary management of adrenocortical carcinoma: A narrative review. Urologic Oncology: Seminars and Original Investigations.
- 2. Bhandare MS (2026). Structured Adaptability in HPB Cancer Surgery: Precision Beyond Technical Uniformity. Annals of Surgical Oncology.
- 3. Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of postpancreatectomy acute pancreatitis, postoperative pancreatic fistula, and mortality after pancreatoduodenectomy: Insight from a comprehensive cohort study of 1,594 patients and development of predictive nomograms. Journal of the American College of Surgeons 242(6):1538-1552.
- 4. Dwivedi P, Barage S, Jha AK, Agrawal A, Rangarajan, V. (2026). External Validation of PET Radiomics-Based ML Model for Non-Invasive Lung Cancer Subtype Classification. Biomedical & Pharmacology Journal, 19(1), 625.
- 5. Kashid SR, Budrukkar A, Swain M, Laskar SG, Murthy V, Gupta T, Sasidharan A, Patil V, Joshi A, Noronha V, Mittal N, Mahimkar M, Patil A, Patel U, Sinha S, Kumar A, Menon N, Bal M, Prabhash K, Agarwal JP. Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy. Cancer Medicine.;15(5):e71854. .
- 6. Gupta S, Rajendran A, Chichra A, Qureshi A (2026). Simultaneous Presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a Patient with Underlying Germline Homozygous STXBP2 Mutation. Mediterranean Journal of Hematology and Infectious Diseases. 18(1):e2026043. Thesis
Akash Maity. 2026. Uncovering the Molecular Pathogenesis of Acute Promyelocytic Leukemia Associated Coagulopathy. ( LIFE09202104023) (Guide: Dr. Syed K Hasan).
Suhail Ahmad. 2025. Integrative Analysis to Understand the Mechanism of Hormone Therapy Resistance in Breast Cancer. (LIFEE09201704014)(Guide: Dr. Syed K Hasan)

Upcoming Events
May 28-29, 2026
At RRU Building, ACTREC, Kharghar
June 15-17, 2026
At ACTREC, Tata Memorial Centre
June 25-27, 2026
Online Workshop, by ACTREC, Tata Memorial Centre
Do You Know?
In 2015, FDA approved talimogene laherparepvec (T-VEC) for the treatment of some patients with metastatic melanoma that cannot be surgically removed.

Cancer News
MedicalXpress, 13/05/2026
The novel cell therapy reprograms the body's own immune system to recognize and attack a specific protein found on the surface of glioblastoma cells, called the urokinase receptor (uPAR)...
News-Medical.Net , 12/05/2026
The device, called PrecisionView, is a handheld endomicroscope that overcomes limitations in medical imaging by combining advanced optics with deep learning. The system enables clinicians to visualize both subcellular structures and underlying blood vessels across large tissue areas without...
Sciencedaily, 12/05/2026
Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These senescent cells survive by relying on a protective protein called GPX4, even while sitting on the edge of a deadly iron-triggered collapse...
© 2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)



